Crizotinib reduces tumor size in patients with ALK positive lung cancer
2012-09-07
(Press-News.org) Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase (ALK) positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and should be the standard of care for advanced stages of this disease, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC) and The University of Chicago.
ALK gene rearrangements are found in around 5 percent of lung cancer tumors and are more common in people with lung cancer who never smoked. Crizotinib is an oral drug that was found to inhibit the effects of the ALK gene and to stop or reverse tumor growth.
In this phase II trial, researchers followed 901 patients for safety and 261 patients for tumor response; all of the patients had at least one prior chemotherapy treatment for their lung cancer. The overall response rate to crizotinib treatment was 60 percent and the median progression free survival (PFS) was eight months, confirming prior findings that crizotinib shrinks ALK-positive lung cancers and demonstrates a high PFS rate.
"This trial demonstrates that we have a good opportunity to shrink cancers and improve symptoms for patients with this subtype of lung cancer," said Gregory Riely, MD, PhD, lead author of the study and a medical oncologist at Memorial Sloan-Kettering Cancer Center in New York who specializes in treating lung cancer. "This confirms the results of prior studies and further shows that crizotinib can reduce the effects of symptoms,
thereby improving the quality of life for thousands of patients who are diagnosed with this late-stage lung cancer. This study confirms that crizotinib is the standard of care for patients with ALK positive lung cancer."
INFORMATION:
The abstract, "Results of a Global Phase II Study with Crizotinib in Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)," will be presented during the Plenary Session at 12:30 p.m., Central time on September 7, 2012. To speak with Gregory Riely, MD, PhD, please call Michelle Kirkwood or Nicole Napoli on September 6-8, 2012, in the press office at the Chicago Marriott Downtown Magnificent Mile at 312-595-3188. You may also send an email to michellek@astro.org or nicolen@astro.org.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-09-07
COLLEGE PARK, Md. - From a public policy point of view, the national debt accumulation since President Obama took office is largely a result of policies put in place prior to his inauguration, says a new analysis by University of Maryland expert Philip Joyce. He adds that Obama's policies will make little impact in the debt over the next decade.
"The best that can be said about presidential fiscal policies thus far is that they would slow the bleeding, but they neither would stop it nor would they do much to heal the patient," Joyce says.
The size of the debt has been ...
2012-09-07
Today, technicians in Minnesota will begin to position the first block of a detector that will be part of the largest, most advanced neutrino experiment in North America.
The NuMI Off-Axis Neutrino Appearance experiment – NOvA for short – will study the properties of neutrinos, such as their masses, and investigate whether they helped give matter an edge over antimatter after both were created in equal amounts in the big bang. The experiment is on track to begin taking data in 2013.
"This is a significant step toward a greater understanding of neutrinos," said Marvin ...
2012-09-07
A neutron detector developed for studies focused on life science, drug discovery and materials technology has been licensed by PartTec Ltd. The Indiana-based manufacturer of radiation detection technologies is moving the technology developed at the U.S. Department of Energy's Oak Ridge National Laboratory toward the commercial marketplace.
The Neutron-Sensitive Anger Camera allows researchers to study a wider variety of crystalline structures, supporting studies in biology, earth science, geology, materials science and condensed matter physics.
"This ORNL detector system, ...
2012-09-07
BUFFALO, N.Y. -- We hear all the time that we need to get off the couch, stop watching TV and get moving.
But what if watching TV under specific conditions could actually provide the mental boost you need to tackle a difficult task?
A new paper that describes two studies by Jaye Derrick, PhD, research scientist at the University at Buffalo's Research Institute on Addictions, found that watching a rerun of a favorite TV show may help restore the drive to get things done in people who have used up their reserves of willpower or self-control.
"People have a limited pool ...
2012-09-07
ENERGY – Revolutionary heat pump . . .
Oak Ridge National Laboratory and Oklahoma's ClimateMaster Inc. have collaborated to develop a ground source heat pump that can reduce a homeowner's electric bill by up to 60 percent. The Trilogy 40 is the first geothermal heat pump certified by the Air Conditioning, Heating and Refrigeration Institute to achieve a space cooling efficiency rating in excess of 40 EER (energy efficiency ratio). An EER rating of 13.5 is typical of conventional heat pumps. For a family living in a 2,600-square-foot well-insulated home, that translates ...
2012-09-07
URBANA – As a college student, you may be happy simply not to have gained the "Freshman 15." But a University of Illinois study shows that as little as 1.5 pounds per year is enough to raise blood pressure in that age group, and the effect was worse for young women.
"In our study, a small weight gain was enough to raise a college student's systolic blood pressure by 3 to 5 points. If young people continue to gain 1.5 pounds a year and think it doesn't matter, they're misleading themselves and increasing their risk for heart disease," said Margarita Teran-Garcia, a U of ...
2012-09-07
A new study published in a special issue of Substance Abuse finds that recovering alcoholics who help others in 12-step programs furthers their time sober, consideration for others, step-work, and long-term meeting attendance.
These novel findings are from a 10-year, prospective investigation led by Maria Pagano, PhD, associate professor of psychiatry at Case Western Reserve University School of Medicine and principal investigator of the "Helping Others" study. Dr. Pagano and colleagues evaluated the decade long of treatment outcomes using data from a single site in ...
2012-09-07
Boston, Mass. - Sepsis, or bacterial infection of the bloodstream, is a grave, hard-to-diagnose threat in premature newborns in the NICU. Even when it's detected and treated with antibiotics, its inflammatory effects can harm fragile babies' development. Now, researchers at Boston Children's Hospital have modeled the effects of sepsis on the unique newborn immune system, using mice. They and others have begun using the model to identify diagnostic markers and better treatments.
The new model is described September 6 in the online open-access journal PLOS ONE (available ...
2012-09-07
SALT LAKE CITY Sept. 6, 2012 - University of Utah engineers mapped white blood cells called eonsinophils and showed an existing diagnostic method may overlook an elusive digestive disorder that causes swelling in the esophagus and painful swallowing.
By pinpointing the location and density of eosinophils, which regulate allergy mechanisms in the immune system, these researchers suggest the disease eosinophilic esophagitis, or EoE, may be under- or misdiagnosed in patients using the current method, which is to take tissue samples (biopsies) with an endoscope.
These ...
2012-09-07
SAN FRANCISCO, Sept. 6, 2012 -- After last year's accidental discovery of "zombie"-like bees infected with a fly parasite, SF State researchers are conducting an elaborate experiment to learn more about the plight of the honey bees.
The scientists are tagging infected bees with tiny radio trackers, and monitoring the bees' movements in and out of a specially designed hive on top of the Hensill Hall biology building on campus. At the same time, they are monitoring hives on campus and on the roof of the San Francisco Chronicle's offices for further signs of the mysterious ...
LAST 30 PRESS RELEASES:
[Press-News.org] Crizotinib reduces tumor size in patients with ALK positive lung cancer
